跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG
Approved
STANDARD
CICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG
Seacross Pharma (Europe) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 13, 2025
Approval ID
bd7ca3d4254ac0c4
Company
Seacross Pharma (Europe) Limited
Type
Standard
Approval Details
Approval Id
bd7ca3d4254ac0c4
Drug Cima Aemps Name
CICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG
Register Number
90201
Holder Company Name
Seacross Pharma (Europe) Limited
Marketing Company Name
Pharmavic Iberica S.L.
Authorization Date
2025-03-13
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose
1.000 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Seacross Pharma (Europe) Limited
Active Ingredients
CICLOFOSFAMIDA MONOHIDRATO
1.069 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 13, 2025
Approval ID
bd7ca3d4254ac0c4
Type
Standard
Back to CIMA-AEMPS Approvals